APO RESEARCH · REPORT
Opioids Drug
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Product & engineering
Understand the product.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Selected research
Industry Research
Opioids Drug Industry Research Report 2026
Market perspective
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
Report Scope
Read the full market overview
This report quantifies the global Opioids Drug market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Opioids Drug Market by Company
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Opioids Drug Segment by Type
Oxycodone
Hydromorphone
Codeine
Fentanyl
Opioids Drug Segment by Application
Pain Relief
Anesthesia
Others
Opioids Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioids Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioids Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioids Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Opioids Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Opioids Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Opioids Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oxycodone
- Hydromorphone
- Codeine
- Fentanyl
Applications
- Pain Relief
- Anesthesia
- Others
Companies covered
- Teva
- Purdue Pharma
- Mallinckrodt
- Amneal Pharma
- Collegium
- J&J
- Endo
- Pfizer
- INSYS
- Mylan
- Hikma
- Egalet
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Opioids Drug Market Size (2021-2032)
- 2.2.2 Global Opioids Drug Sales (2021-2032)
- 2.2.3 Global Opioids Drug Market Average Price (2021-2032)
- 2.3 Opioids Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oxycodone
- 2.3.3 Hydromorphone
- 2.3.4 Codeine
- 2.3.5 Fentanyl
- 2.4 Opioids Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pain Relief
- 2.4.3 Anesthesia
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Opioids Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Opioids Drug Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Opioids Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Opioids Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Opioids Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Opioids Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Opioids Drug, Product Type & Application
- 3.8 Global Manufacturers of Opioids Drug, Established Date
- 3.9 Global Opioids Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Opioids Drug Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Purdue Pharma
- 4.2.1 Purdue Pharma Company Information
- 4.2.2 Purdue Pharma Business Overview
- 4.2.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Purdue Pharma Opioids Drug Product Portfolio
- 4.2.5 Purdue Pharma Recent Developments
- 4.3 Mallinckrodt
- 4.3.1 Mallinckrodt Company Information
- 4.3.2 Mallinckrodt Business Overview
- 4.3.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mallinckrodt Opioids Drug Product Portfolio
- 4.3.5 Mallinckrodt Recent Developments
- 4.4 Amneal Pharma
- 4.4.1 Amneal Pharma Company Information
- 4.4.2 Amneal Pharma Business Overview
- 4.4.3 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Amneal Pharma Opioids Drug Product Portfolio
- 4.4.5 Amneal Pharma Recent Developments
- 4.5 Collegium
- 4.5.1 Collegium Company Information
- 4.5.2 Collegium Business Overview
- 4.5.3 Collegium Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Collegium Opioids Drug Product Portfolio
- 4.5.5 Collegium Recent Developments
- 4.6 J&J
- 4.6.1 J&J Company Information
- 4.6.2 J&J Business Overview
- 4.6.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 J&J Opioids Drug Product Portfolio
- 4.6.5 J&J Recent Developments
- 4.7 Endo
- 4.7.1 Endo Company Information
- 4.7.2 Endo Business Overview
- 4.7.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Endo Opioids Drug Product Portfolio
- 4.7.5 Endo Recent Developments
- 4.8 Pfizer
- 4.8.1 Pfizer Company Information
- 4.8.2 Pfizer Business Overview
- 4.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pfizer Opioids Drug Product Portfolio
- 4.8.5 Pfizer Recent Developments
- 4.9 INSYS
- 4.9.1 INSYS Company Information
- 4.9.2 INSYS Business Overview
- 4.9.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 INSYS Opioids Drug Product Portfolio
- 4.9.5 INSYS Recent Developments
- 4.10 Mylan
- 4.10.1 Mylan Company Information
- 4.10.2 Mylan Business Overview
- 4.10.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Mylan Opioids Drug Product Portfolio
- 4.10.5 Mylan Recent Developments
- 4.11 Hikma
- 4.11.1 Hikma Company Information
- 4.11.2 Hikma Business Overview
- 4.11.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hikma Opioids Drug Product Portfolio
- 4.11.5 Hikma Recent Developments
- 4.12 Egalet
- 4.12.1 Egalet Company Information
- 4.12.2 Egalet Business Overview
- 4.12.3 Egalet Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Egalet Opioids Drug Product Portfolio
- 4.12.5 Egalet Recent Developments
5 Global Opioids Drug Market Scenario by Region
- 5.1 Global Opioids Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Opioids Drug Sales by Region: 2021-2032
- 5.2.1 Global Opioids Drug Sales by Region: 2021-2026
- 5.2.2 Global Opioids Drug Sales by Region: 2027-2032
- 5.3 Global Opioids Drug Revenue by Region: 2021-2032
- 5.3.1 Global Opioids Drug Revenue by Region: 2021-2026
- 5.3.2 Global Opioids Drug Revenue by Region: 2027-2032
- 5.4 North America Opioids Drug Market Facts & Figures by Country
- 5.4.1 North America Opioids Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Opioids Drug Sales by Country (2021-2032)
- 5.4.3 North America Opioids Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Opioids Drug Market Facts & Figures by Country
- 5.5.1 Europe Opioids Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Opioids Drug Sales by Country (2021-2032)
- 5.5.3 Europe Opioids Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Opioids Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Opioids Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Opioids Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Opioids Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Opioids Drug Market Facts & Figures by Country
- 5.7.1 South America Opioids Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Opioids Drug Sales by Country (2021-2032)
- 5.7.3 South America Opioids Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Opioids Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Opioids Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Opioids Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Opioids Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Opioids Drug Sales by Type (2021-2032)
- 6.1.1 Global Opioids Drug Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Opioids Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Opioids Drug Revenue by Type (2021-2032)
- 6.2.1 Global Opioids Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Opioids Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Opioids Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Opioids Drug Sales by Application (2021-2032)
- 7.1.1 Global Opioids Drug Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Opioids Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Opioids Drug Revenue by Application (2021-2032)
- 7.2.1 Global Opioids Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Opioids Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Opioids Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Opioids Drug Value Chain Analysis
- 8.1.1 Opioids Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Opioids Drug Production Mode & Process
- 8.2 Opioids Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Opioids Drug Distributors
- 8.2.3 Opioids Drug Customers
9 Global Opioids Drug Analyzing Market Dynamics
- 9.1 Opioids Drug Industry Trends
- 9.2 Opioids Drug Industry Drivers
- 9.3 Opioids Drug Industry Opportunities and Challenges
- 9.4 Opioids Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst